Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Jane Street Group LLC

Jane Street Group LLC cut its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 20.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 242,602 shares of the company's stock after selling 60,681 shares during the period. Jane Street Group LLC owned approximately 0.28% of Pediatrix Medical Group worth $3,183,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Nomura Asset Management Co. Ltd. boosted its holdings in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after buying an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after buying an additional 1,040 shares during the last quarter. AlphaQuest LLC boosted its holdings in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after buying an additional 2,012 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after buying an additional 6,090 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its holdings in Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after buying an additional 5,104 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Up 0.1%

Shares of MD stock traded up $0.01 during trading on Friday, hitting $14.89. 785,750 shares of the stock traded hands, compared to its average volume of 853,740. The firm has a market capitalization of $1.28 billion, a P/E ratio of -12.41, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The firm's fifty day moving average price is $13.71 and its 200-day moving average price is $14.09. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.20 EPS. As a group, research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

MD has been the topic of several research analyst reports. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Truist Financial decreased their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Macquarie raised their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Finally, UBS Group decreased their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 12th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.